Encephalitis, Tick-Borne
Conditions
Keywords
TBE, vaccine, adults
Brief summary
The purpose of this study it is to evalutate the persistence of antibodies after a booster immunisation with a TBE vaccine for adults
Interventions
Sponsors
Study design
Eligibility
Inclusion criteria
* Healthy volunteers of both sexes aged \>18 who participated in another study on TBE vaccination
Exclusion criteria
* Subjects with any condition, in the opinion of the Investigator, might interfere with the evaluation of the study objectives.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Long-term antibody kinetics as measured both by ELISA and neutralisation test (NT) five years after first booster immunization. | — |
Secondary
| Measure | Time frame |
|---|---|
| Booster response in a subset of subjects as measured by NT, ELISA and cellular immunity on Days 3, 5, 7 and 21 after 2nd booster immunization. | — |
Countries
Germany